A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids.
Tracy L Brewer, Margie Collins
Journal for Specialists in Pediatric Nursing April 2014 DOI: 10.1111/jspn.12057 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Population | Adolescents and young adults who use synthetic cannabinoids, as described in reviewed case studies |
| Keywords | Adolescent Clinical manifestation Synthetic cannabinoid Synthetic marijuana Young adult |
| Key findings | Reviewed case studies suggest synthetic cannabinoid use produces unpredictable negative psychological and physiological effects, most commonly anxiety, agitation, paranoia, hallucinations, tachycardia, nausea and vomiting, and diaphoresis. The authors argue that familiarity with these manifestations can guide supportive nursing management of suspected users. |
Abstract
The purpose of this review is to heighten the awareness of the increased use and risks of synthetic cannabinoids (SCs) and associated clinical manifestations among adolescents and young adults. Reviewed case studies suggest that the use of SCs have unpredictable negative psychological and physiological effects. Predominant manifestations reported were anxiety, agitation, paranoia, hallucinations, tachycardia, nausea and vomiting, and diaphoresis. Nurses provide the most direct and supportive care to patients who present for medical treatment after the use of SCs. Knowledge of clinical manifestations can facilitate supportive management of patients suspected of SCs use.
Citations in the library
Cited by 5
- Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Frontiers in Neuroscience April 19, 2016
- Legal highs: staying on top of the flood of novel psychoactive substances Therapeutic Advances in Psychopharmacology January 26, 2015
- Designer drugs 2015: assessment and management Addiction Science & Clinical Practice March 11, 2015
- What are the psychological effects of using synthetic cannabinoids? A systematic review Journal of Psychopharmacology February 21, 2019
- New synthetic drugs in addictovigilance. The´rapie 2015
Cites 4
- Beyond THC: The New Generation of Cannabinoid Designer Drugs Frontiers in Behavioral Neuroscience 2011
- Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light Frontiers in Behavioral Neuroscience 2011
- JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. British Journal of Pharmacology June 2010
- Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Deutsches Arzteblatt international July 3, 2009